Group Structure
Bumrungrad Hospital Public Company Limited (the “Company”) operates a private hospital business in Bangkok with 580 licensed beds and a capacity for over 5,500 outpatients per day. The Company is one of the leading healthcare providers, not only in Thailand, but in the whole of Southeast Asia, providing world-class holistic and innovative healthcare services for both outpatients and inpatients.
The Company has always emphasized the importance of quality healthcare and experienced physicians and staff, as well as cutting edge medical equipment. We also place great importance in the development of business innovation to fully meet patients’ changing needs.
Bumrungrad International Hospital, Bangkok, is the first hospital in Asia to receive US standard accreditation from the Joint Commission International (JCI); the first hospital to be approved by Thai Hospital Accreditation (HA) and to subsequently receive Advanced Healthcare Accreditation (AHA); the world’s first hospital to receive Global Healthcare Accreditation (GHA) Certification of Conformance with GHA Covid-19 Guidelines for our Covid-19 management excellence; and the first hospital in Thailand to receive accreditation from the College of American Pathologists (CAP).
Moreover, Bumrungrad International Hospital has been consistently nominated by Newsweek for three consecutive years (2021, 2022, and 2023) as one of the world’s top hospitals and Thailand’s No. 1 hospital. Bumrungrad International Hospital has also been recognized as one of the top 330 World’s Best Smart Hospitals. Additionally, Bumrungrad International Hospital was honored with the Best Company Performance Awards at the SET Awards 2023, organized by the Stock Exchange of Thailand and Money and Banking Magazine.
* Click here to view large image
The Company has 11 subsidiaries, namely (1) Asia Global Health Limited, (2) Asia Global Research Company Limited, (3) Bumrungrad Health Network Company Limited (formerly known as Bumrungrad Personnel Development Center Company Limited), (4) Bumrungrad International Hospital Phuket Company Limited, (5) Bumrungrad Personnel Development and Training Center Company Limited, (6) Bumrungrad Services Company Limited, (7) Health Horizons Enterprises Pte. Ltd., (8) Life and Longevity Limited, (9) Ruenmongkol Company Limited, (10) Vitallife Corporation Limited, and (11) Vitallife Allianz Company Limited.
The Company also has seven indirect subsidiaries, namely (1) Bumrungrad Myanmar Company Limited (80%-owned through Bumrungrad Health Network Company Limited), (2) Bumrungrad Mongolia LLC (80%-owned through Bumrungrad Health Network Company Limited which acquired the shares from Health Horizons Enterprises Pte. Ltd. in 2023), (3) Bumrungrad Spine Network Company Limited (75%-owned through Bumrungrad Health Network Company Limited), (4) Keyoniq Switzerland AG (100%-owned through Bumrungrad Health Network Company Limited), (5) Lifestyletech Solution Company Limited (100%-owned through Bumrungrad Services Company Limited) (formerly P53 Life Sciences Company Limited), (6) Seoul Seniors Towers LLC (approx. 41%-owned with control as per its shareholding portion through Bumrungrad Health Network Company Limited and Bumrungrad Mongolia LLC), and (7) Vitallife Switzerland AG (100%-owned through Bumrungrad Health Network Company Limited) (formerly Inovital International AG, 49%-indirect owned through Life and Longevity Limited).
The Company has two associated companies, namely (1) 50%-owned BB Health Venture Company Limited and (2) 50%-indirectly owned RAKxa Venture Company Limited through Vitallife Allianz Company Limited. The 31.5 %-owned Bumrungrad International Limited has registered its completion of liquidation on 30 June 2022.
Details of subsidiaries, affiliated companies, and associated companies are as follows:
Asia Global Health Limited (“AGH”) has served as a company that supports the strategy for regional investment in healthcare and related business. It is now a dormant company.
Asia Global Research Company Limited (“AGR”) is the provider of clinical research, both within Thailand and Southeast Asia. Acting as the contract research organization (CRO), AGR conducts research and provides drug R&D planning advice for pharmaceutical companies, medical equipment first, and other clinical research companies with the purpose of achieving quality and precise research outcomes and information. AGR also operates the Esperance Integrative Cancer Clinic, iConic drug store, and direct marketing.
Bumrungrad Health Network Company Limited (“BHN”) (previously Bumrungrad Personnel Development Center Co., Ltd.) is a company that focuses on investing in healthcare and related businesses, both domestic and overseas.
Bumrungrad International Hospital Phuket Company Limited ("BIHP") operates the services business of sanatorium.
Bumrungrad Myanmar Company Limited ("BM”) operates a private primary care and medical diagnostic services clinic in Myanmar.
Bumrungrad Mongolia LLC (“BML”) is a holding company registered in Mongolia, which supports the Company’s strategy for overseas investment in healthcare and related businesses.
Bumrungrad Personnel Development and Training Center Company Limited ("BPDTC”) is a personnel development and training company that focuses on improving and expanding the capabilities of clinical and healthcare services to the Company and affiliated companies only.
Bumrungrad Services Company Limited (“BS”) is a company that supports the strategy for referral services to both domestic and foreign patients and provides healthcare-related training services to non-affiliated companies.
Bumrungrad Spine Network Company Limited (“BSN”) is a company that provides consulting and management services to healthcare facilities.
Health Horizons Enterprises Pte. Ltd. (“HHE”) is a holding company registered in Singapore, which supports the Company’s strategy for overseas investment in healthcare and related businesses.
Keyoniq Switzerland AG ("KYQ") is a research and development company that provides AI powered data centric software applications for the healthcare domain.
Life and Longevity Limited (“LLL”) registered in Hong Kong Special Administrative Regions of the People's Republic of China, is a holding company for overseas investments of the Company.
Lifestyletech Solution Company Limited ("LTS") (formerly P53 Life Sciences Co., Ltd. (“PLS”)) operates digital platform service business.
Ruenmongkol Company Limited (“RM”) is the owner of the land at Sukhumvit Soi 1 (approx. 3-3-44.4 rai). The Company has constructed a car park building thereon.
Seoul Seniors Towers LLC (“SST”) is a company that owns and operates Ulaanbaatar Songdo Hospital in Mongolia.
Vitallife Corporation Limited (“Vitallife”) is a pioneer in longevity medicine, integrating predictive, preventive, rejuvenating, and regenerative strategies for optimal healthy lifestyles. Vital Life brings together cutting-edge technologies to provide patients with the means to “Feel Younger, Look Better, and Live Longer”. Biomarker analysis, advanced supplementation, toxicity assessments, early detection, and regenerative medicine are key Vital Life analytics. Vitallife also operates a skin clinic and a direct marketing business selling organic cosmetic products as well.
Vitallife Allianz Company Limited (“VTLA”) is a company that operates a wellness clinic at Bangkrajao in Thailand.
Vitallife Switzerland AG ("VTLS") (formerly Inovital International AG (“Inovital”)). BHN acquired all the shares of Inovital and changed the company's name to VTLS in quarter three of 2023. VTLS sells and delivers innovative, science-based medical treatment services and products for predictive, preventive, revitalizing and regenerative care.
BB Health Venture Company Limited ("BBHV") is a joint venture company formed by Bumrungrad Hospital Public Company Limited and BTS Group Holdings Public Company Limited. It engages in the business of sanatorium.
RAKxa Venture Co., Ltd. (“RAKxa”) is a joint venture company formed by Vitallife Allianz Company Limited and Rx Wellness Company Limited, a subsidiary of M.K. Real Estate Development Public Company Limited. It engages in the business of a wellness center, clinic and medical center, and rehabilitation center.
Bumrungrad International Limited (“BIL”) served as the Company's international investment arm. BIL had focused on hospital ownership and management. In 2023, BIL ceased its operating activity and pursued the distribution of its funds to shareholders via capital reduction. BIL was dissolved on 28 December 2017 and registered its completion of liquidation on 30 June 2022.
